Vanguard Group Inc My Md Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.92 - $96.0 $588 - $61,440	640 Added 0.04%	1,458,295 $1.68 Million
Q1 2022 May 13, 2022	SELL	$3.34 - $6.05 $23,740 - $43,003	-7,108 Reduced 0.49%	1,457,655 $6.79 Million
Q4 2021 Feb 14, 2022	SELL	$5.46 - $9.69 $319,633 - $567,262	-58,541 Reduced 3.84%	1,464,763 $8.88 Million
Q3 2021 Nov 12, 2021	SELL	$4.64 - $7.94 $9,358 - $16,014	-2,017 Reduced 0.13%	1,523,304 $11 Million
Q2 2021 Aug 13, 2021	BUY	$3.39 - $6.98 $5.17 Million - $10.6 Million	1,525,321 New	1,525,321 $9.61 Million

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.